16:25 PMExpress Scripts (ESRX): Q3 EPS ex-items of $0.81 beats by $0.01. Revenue of $5.6B (+3%) vs. $5.5B. Sees full-year EPS of $3.76-3.82 vs. $3.49. (PR)
Comment!
16:15 PMExpress Scripts (ESRX): Q2 EPS of $0.88 beats by $0.02. Revenue of $5.5B (-0.5%) in-line. Sees full-year EPS of $3.72-3.82 vs. consensus of $3.58, citing strong underlying fundamentals in the core business. Shares +1.3% AH. (PR)
Comment!
06:58 AM
Express Scripts (ESRX) will buy WellPoint's (WLP) in-house pharmacy-benefit management business for $4.68B. The cash-stock deal will help Express Scripts compete against larger rivals like CVS Caremark (CVS) and Medco Health Solutions (MHS).
Comment!
Wednesday, February 25, 2009
16:09 PMExpress Scripts (ESRX): Q4 EPS of $0.83 in-line. Revenue of $5.51B (-0.9%) vs. $5.45B. Shares -2.7% AH. (PR)
Comment!
16:16 PMExpress Scripts (ESRX): Q2 EPS of $0.76 beats by $0.04. Revenue of $4.71B (+2.9%) in-line. Sees full-year EPS of $3.03-3.10 vs. $3.00. Will buy back another 15M shares. Shares +2%. [PR]
Comment!